ARTELO BIOSCIENCES INC C/WTS 25/06/2024(TO PUR COM) ARTLW 深 沪
已收盘 06-17 16:00:00 美东时间
0.0056
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0056
- 总市值 1.87万
- 52周最高 0.1498
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.005
- 委 比 0.00%
- 总股本 334.74万
- 历史最高 1.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.005
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Artelo Biosciences Approves Common Stock Increase
An update from Artelo Biosciences ( ($ARTL) ) is now available. On August 28, 2...
08-30 04:58
Artelo Biosciences Secures European Patent For ART27.13 Commercial Formulation, Extending Protection Through 2041; Phase 2 Trial Advances For Cancer-Related Anorexia Treatment
Extends Patent Protection Through December 2041ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related AnorexiaSOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo
08-11 21:17
Artelo Biosciences shares are trading higher after the company received written scientific advice from the UK MHRA affirming the proposed design for its Phase 1 trial of ART12.11.
Artelo Biosciences shares are trading higher after the company received written...
08-01 19:51
Artelo Biosciences Announces At-The-Market Offering Agreement
The latest update is out from Artelo Biosciences ( ($ARTL) ). On July 18, 2025,...
07-19 04:57
Artelo Biosciences Analyst See It As An Emerging Biotech
Artelo gets Buy rating from Boral Capital after positive updates on ART27.13, ART26.12, and preclinical success of its candidate for depression.
07-09 03:06
D. Boral Capital Upgrades Artelo Biosciences to Buy, Announces $20 Price Target
D. Boral Capital analyst Jason Kolbert upgrades Artelo Biosciences (NASDAQ:ARTL) from Hold to Buy and announces $20 price target.
07-08 19:12
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neurogene (NASDAQ:NGNE) shares increased by 32.3% to $19.77 during Tue...
07-02 01:05
Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday?
Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in 49 healthy participants.
06-30 22:18
